Abstract Objectives Hyperhomocysteinemia in Alzheimer's disease (AD) is widely reported
and appears to worsen as the disease progresses. While active dietary intervention with …

Hyperhomocysteinemia (HHcy) is supposed to be one of the modifiable risk factors that, if
treated, may delay the onset of Alzheimer's disease (AD). The relation between serum …

OBJECTIVE Authors determined the impact of high-dose vitamin supplements on plasma
homocysteine levels in patients with Alzheimer disease (AD). METHODS Authors used an …

Elevated total plasma homocysteine has been linked to the development of cognitive
impairment and dementia in later life and this can be reliably lowered by the daily …

Epidemiological and clinical studies indicate that elevated circulating level of homocysteine
(Hcy) is a risk factor for developing Alzheimer's disease (AD). Dietary deficiency of folate …

Objective Hyperhomocysteinemia (HHcy), as an important risk factor for Alzheimer's disease
(AD), would aggravate cognitive dysfunction. This study aimed to investigate whether and to …

DEMENTIA IS HIGHLY PREVALENT AMONG ELDERLY PEOPLE, and projections show
that the number of people affected might triple over the next 50 years, mainly because of a …

Objective Moderately elevated levels of plasma total homocysteine are associated with an
increased risk of developing Alzheimer's disease. We have tested whether baseline …

Background Homocysteine is a risk factor for Alzheimer's disease. In the first report on the
VITACOG trial, we showed that homocysteine‐lowering treatment with B vitamins slows the …

Background An increased rate of brain atrophy is often observed in older subjects, in
particular those who suffer from cognitive decline. Homocysteine is a risk factor for brain …